Results 191 to 200 of about 1,398,780 (286)

Immunological In Vitro Assay for Quantification of Adjuvanted Allergoids

Allergy, EarlyView.
An assay was developed to measure the allergoid content in adjuvanted grass allergoid AIT drug product (AIT‐DPs) at the finished product level. Both polyclonal rabbit sera or a mouse anti‐Phl p 5 mAb can be used, allowing differential product analysis.
S. Schlünder, J. Echternach, D. Bartel, V. Mahler, M. D. Mühlebach, F. Führer   +5 more
wiley   +1 more source

Promising Vaccine Formulations for Emerging Infectious Diseases. [PDF]

Int J Mol Sci
Park PG, Lee SY, Youn H, Hong KJ.
europepmc   +1 more source

Update on andrological effects of SARS‐CoV‐2 infection and COVID‐19: An overview review

Andrology, EarlyView.
Abstract Background Evidence indicates a wide range of andrological alterations in patients with the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS‐CoV‐2) infection and Coronavirus Disease 2019 (COVID‐19). Aim To provide an update on the andrological effects of SARS‐CoV‐2 infection and COVID‐19.
Giuseppe Lisco, Anna De Tullio, Maima Matin, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Giuseppina Piazzolla, Vincenzo Triggiani   +7 more
wiley   +1 more source

rLVS Δ<i>capB</i>/Yp F1-V single vector platform vaccine expressing <i>Yersinia pestis</i> F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli. [PDF]

Hum Vaccin Immunother
Jia Q, Bowen RA, Masleša-Galić S, Horwitz MA.   +3 more
europepmc   +1 more source

The Paediatric BCG Vaccine Century: From Historical Success to Future Innovations

Acta Paediatrica, EarlyView.
ABSTRACT Aim The tuberculosis (TB) vaccine, Bacille‐Calmette‐Guérin (BCG), protects infants against severe forms of primary TB. Yet, it does not protect against pulmonary reactivation TB in adults. Methods A literature review was conducted between 1st January and 28th February 2025 using PubMed, Google Scholar and reports of the World Health ...
Stefan H. E. Kaufmann
wiley   +1 more source

Assessment of the Reversion to Virulence and Protective Efficacy in Pigs Receiving the Live Attenuated Classical Swine Fever Recombinant Vaccine Candidate FlagT4G. [PDF]

Vaccines (Basel)
Ramirez-Medina E, Velazquez-Salinas L, Valladares A, Rai A, Burton L, Sastre L, Silva E, Risatti GR, Ganges L, Borca MV.   +9 more
europepmc   +1 more source

Efficacy and safety of HRS‐5965 monotherapy in complement inhibitor–naïve patients with paroxysmal nocturnal haemoglobinuria

British Journal of Haematology, EarlyView.
Summary Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, life‐threatening disorder characterized by complement‐mediated haemolysis, leading to anaemia and thrombosis. HRS‐5965 is a novel, oral, selective complement factor B inhibitor targeting the alternative pathway, potentially reducing both intra‐ and extravascular haemolysis.
Li Zhang, Ziwei Liu, Xin Zhao, Bin Hu, Rong Huang, Chang Shu, Fengkui Zhang, Bing Han   +7 more
wiley   +1 more source

Humoral immunity is sufficient to protect mice against Rift Valley fever encephalitis following percutaneous exposure. [PDF]

NPJ Vaccines
Mueller Brown K, Barbeau DJ, Xu L, Bird BH, McElroy AK.   +4 more
europepmc   +1 more source

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy

British Journal of Pharmacology, EarlyView.
Abstract Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear.
Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang
wiley   +1 more source

Pathogenicity and virulence of lumpy skin disease virus: A comprehensive update. [PDF]

Virulence
Kumar N, Sharma S, Tripathi BN.
europepmc   +1 more source